© 2020 MJH Life Sciences and Psychiatric Times. All rights reserved.
July 10, 2020
Treatment strategies for antipsychotic-induced hyperprolactinemia.
July 07, 2020
This form of nonsuicidal self-injury occurs within a spectrum of severity, and it is very likely that cases are both underreported and unpublished.
June 30, 2020
Despite the vast research conducted to better understand biological mechanisms underlying psychosis, people with psychotic disorders continue to suffer.
Those of us who have a diagnosis of a psychotic disorder are, above all, human beings. We are more than the disorder.
Psychotic disorders are potentially serious and enduring and have been seriously neglected in health systems worldwide. The good news is that better medium-term outcomes are now achievable.
June 17, 2020
Drs Zuardi and Crippa discuss the current stage of scientific evidence that supports the use of cannabidiol in schizophrenia, anxiety, and Parkinson disease.
June 11, 2020
As we move forward from COVID-19, we take a look at noteworthy achievements that took place at lightning speed to inform response measures in future pandemics.
June 08, 2020
Familiarity with self-disorders is an indispensable tool in diagnosing a patient suspected for developing schizophrenia. Such knowledge improves communication with the patient and may serve as a starting point for therapeutic intervention.
June 04, 2020
Psychomotor speed may be a relevant target in studies of the immune system and its impact on the brain in patients with schizophrenia.
There is inadequate information regarding optimal antipsychotic doses in the treatment of acute schizophrenia that balance efficacy and safety. This article helps you get it right.